Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Veziris

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Medecine Et Maladies Infectieuses|September 18, 2016
Multidrug and extensively drug-resistant tuberculosisT Maitre, A Aubry, V Jarlier, et al.
International Journal of STD & AIDS|May 20, 2009
Retrospective review of Pneumocystis jirovecii pneumonia in a French intensive care unit (1994-2000)F Bruneel, N Veziris, S Chevret, et al.
Epidemiology and Infection|November 22, 2007
Evaluation of data quality in a laboratory-based surveillance of M. tuberculosis drug resistance and impact on the prevalence of resistance: France, 2004P M Khuê, A Mallet, N Veziris, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2010
Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosisF Brossier, N Veziris, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in miceN Veziris, N Lounis, A Chauffour, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|October 23, 2004
[Utility of molecular tools in diagnosis, treatment, and epidemiology of mycobacterial infections]N Veziris, A Aubry, W Sougakoff, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 27, 2007
Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistanceN Veziris, C Martin, F Brossier, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 11, 2007
Contact tracing of passengers exposed to an extensively drug-resistant tuberculosis case during an air flight from Beirut to Paris, October 2006J Chemardin, M C Paty, S Renard-Dubois, et al.
Medecine Et Maladies Infectieuses|December 4, 2009
[R207910 (TMC207): a new antibiotic for the treatment of tuberculosis]N Lounis, J Guillemont, N Veziris, et al.
Medecine Et Maladies Infectieuses|March 26, 2011
[Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient]A Prevotat, S Bonne, N Veziris, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Medecine Et Maladies Infectieuses|September 18, 2016
Multidrug and extensively drug-resistant tuberculosisT Maitre, A Aubry, V Jarlier, et al.
International Journal of STD & AIDS|May 20, 2009
Retrospective review of Pneumocystis jirovecii pneumonia in a French intensive care unit (1994-2000)F Bruneel, N Veziris, S Chevret, et al.
Epidemiology and Infection|November 22, 2007
Evaluation of data quality in a laboratory-based surveillance of M. tuberculosis drug resistance and impact on the prevalence of resistance: France, 2004P M Khuê, A Mallet, N Veziris, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2010
Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosisF Brossier, N Veziris, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in miceN Veziris, N Lounis, A Chauffour, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|October 23, 2004
[Utility of molecular tools in diagnosis, treatment, and epidemiology of mycobacterial infections]N Veziris, A Aubry, W Sougakoff, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 27, 2007
Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistanceN Veziris, C Martin, F Brossier, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 11, 2007
Contact tracing of passengers exposed to an extensively drug-resistant tuberculosis case during an air flight from Beirut to Paris, October 2006J Chemardin, M C Paty, S Renard-Dubois, et al.
Medecine Et Maladies Infectieuses|December 4, 2009
[R207910 (TMC207): a new antibiotic for the treatment of tuberculosis]N Lounis, J Guillemont, N Veziris, et al.
Medecine Et Maladies Infectieuses|March 26, 2011
[Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient]A Prevotat, S Bonne, N Veziris, et al.
Pageof 6